ClearPoint Neuro, Inc.

Equities

CLPT

US18507C1036

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 04:00:00 2024-07-16 pm EDT 5-day change 1st Jan Change
7.59 USD +0.93% Intraday chart for ClearPoint Neuro, Inc. +15.35% +11.78%
LockThis article is reserved for members
To unlock the article, REGISTER!
Already a customer? Log In
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 3000E Growth Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell Microcap Value Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2000 Value Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2000 Growth Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2500 Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 3000 Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2000 Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 3000 Value Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 3000 Growth Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2500 Value Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell Small Cap Comp Growth Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2000 Dynamic Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell Small Cap Comp Value Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell Small Cap Completeness Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 3000E Value Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 3000E Index CI
ClearPoint Neuro, Inc.(NasdaqCM:CLPT) dropped from Russell 2500 Growth Index CI
Clinical Laserthermia Systems Gets Additional SEK7.5 Million Orders from ClearPoint Neuro MT
ClearPoint Neuro, Inc. Initiates Its Full Market Release of the Smartframe CI
Clearpoint Neuro Announces Full Market Release of Smartframe or and Clearpoint Prism 3T Laser Therapy System CI
Certain Common Stock of ClearPoint Neuro, Inc. are subject to a Lock-Up Agreement Ending on 29-MAY-2024. CI
Certain restricted stock units of ClearPoint Neuro, Inc. are subject to a Lock-Up Agreement Ending on 29-MAY-2024. CI
Certain stock options of ClearPoint Neuro, Inc. are subject to a Lock-Up Agreement Ending on 29-MAY-2024. CI
ClearPoint Neuro, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (CLPT) CLEARPOINT NEURO Reports Q1 Revenue $7.6M, vs. Street Est of $7M MT
Chart ClearPoint Neuro, Inc.
More charts
ClearPoint Neuro, Inc. is a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. The Company’s flagship product is the ClearPoint Neuro Navigation System. Its initial product offering, the ClearPoint system, is an integrated system comprised of capital equipment and disposable products, designed to allow minimally invasive procedures in the brain to be performed in a magnetic resonance imaging (MRI) suite. The ClearPoint Array Neuro Navigation System and its principal disposable component is designed to be deployed in an operating room setting while also being usable in an MRI suite. It is engaged with healthcare and research centers in North America, Europe, Asia, and South America. It also provides solutions for direct CNS delivery of therapeutics in pre-clinical studies and clinical trials worldwide.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.59 USD
Average target price
10 USD
Spread / Average Target
+31.75%
Consensus
  1. Stock Market
  2. Equities
  3. CLPT Stock
  4. News ClearPoint Neuro, Inc.
  5. Stifel Adjusts Price Target on ClearPoint Neuro to $9 From $8, Maintains Buy Rating